If you’re on Ozempic, semaglutide, or tirzepatide and you have a dental appointment coming up, you may be wondering whether your medication needs to be paused beforehand. The answer depends heavily on what kind of dental work is planned. Routine cleanings are one thing. Procedures involving sedation or significant oral surgery are another. Here’s what the current thinking looks like and what to tell your dental team.<\/p>\n
For the vast majority of dental visits, including cleanings, fillings, crown placements, and other procedures done under local anesthesia only, there’s no clinical reason to stop or pause your GLP-1 medication. Local anesthesia doesn’t suppress airway reflexes the way general anesthesia or deep sedation does, so the aspiration risk that drives pre-operative guidance for surgical procedures simply doesn’t apply in the same way.<\/p>\n
That said, disclosure still matters. Your dentist should know what medications you’re taking, including GLP-1 medications, for the same reason any healthcare provider should have a complete picture of your current treatment. It affects how they interpret any unusual symptoms, how they think about your healing, and whether they need to consult with your prescribing provider for more complex work.<\/p>\n
The picture changes when sedation is involved. Dental procedures performed under nitrous oxide, oral sedation, or intravenous sedation involve varying degrees of consciousness reduction and, with deeper sedation, some suppression of protective airway reflexes.<\/p>\n
This is where the gastric emptying issue becomes relevant. As covered in detail in our article on when to stop Ozempic before surgery<\/a>, GLP-1 medications slow gastric emptying significantly in many patients. If stomach contents are present during a sedated procedure, aspiration becomes a meaningful risk even in a dental chair.<\/p>\n For procedures requiring moderate to deep sedation, the same logic that applies to surgical pre-operative planning applies here. Your dental team and prescribing provider should communicate, and a pre-procedure hold on your GLP-1 medication may be appropriate depending on the depth of sedation planned.<\/p>\n Nitrous oxide alone, sometimes called laughing gas, typically produces only light analgesia and mild anxiolysis without significant airway reflex suppression. Many providers consider this low enough risk that a medication hold isn’t warranted. IV sedation and general anesthesia administered in a dental office or oral surgery center carry more meaningful aspiration risk and warrant the same precautions as hospital-based procedures.<\/p>\n Tooth extractions, wisdom tooth removal, implant placements, and other oral surgical procedures exist on a spectrum. Simple single-tooth extractions under local anesthesia don’t raise the same concerns as full-arch implant surgery under IV sedation.<\/p>\n For oral surgery involving sedation, the pre-operative fasting guidance that applies to hospital procedures should be followed. This typically means holding weekly GLP-1 medications like Ozempic or Wegovy for one week before the procedure, or following whatever individualized guidance your prescribing provider and oral surgeon agree on together.<\/p>\n Let’s say a patient is scheduled for all four wisdom teeth to be removed under IV sedation. He’s been on semaglutide for four months and still experiences mild nausea after larger meals, suggesting some degree of ongoing gastric slowing. His oral surgeon asks about current medications at the pre-operative consult, he discloses his Ozempic use, and the team decides to hold the medication for one week prior. That’s the system working exactly as it should.<\/p>\n Beyond procedural safety, there’s a broader question worth addressing: do GLP-1 medications affect dental and oral health in any ongoing way?<\/p>\n A few factors are worth knowing about. Reduced food intake and dietary changes on GLP-1 medications can alter the oral environment. Patients eating less overall, particularly fewer fermentable carbohydrates, may actually see some improvement in cavity risk over time. But reduced saliva production, which can occur with nausea-driven reduced fluid intake, creates a drier oral environment that increases bacterial growth and cavity susceptibility.<\/p>\n Nausea and acid reflux are common side effects of GLP-1 medications, particularly in the early months of treatment. Frequent acid reflux or vomiting, if it occurs, exposes tooth enamel to stomach acid. Patients experiencing significant reflux on treatment should let their dentist know, as it can affect how they monitor and protect enamel over time. Our article on Ozempic and heartburn<\/a> covers managing that side effect in more detail.<\/p>\n Some patients also report changes in taste perception on GLP-1 medications. Foods that were previously appealing may taste different or less attractive. This is generally benign from a dental standpoint but worth mentioning to your dentist if it affects your eating patterns significantly.<\/p>\n Disclosure is straightforward. Tell your dental provider the name of your GLP-1 medication, the dose, how long you’ve been on it, and whether you experience any GI symptoms like nausea or reflux that might be relevant to your care.<\/p>\n For routine visits, this is informational. For sedated procedures, it opens a conversation about whether a medication hold is appropriate and how to coordinate with your prescribing provider. A good dental team will appreciate the information rather than dismiss it.<\/p>\n If your dentist isn’t familiar with GLP-1 medications, which is entirely possible given how recently this drug class expanded into widespread weight loss use, you can point them toward the American Society of Anesthesiologists’ 2023 guidance on GLP-1 medications and perioperative fasting as a starting reference.<\/p>\n For procedures where a medication hold was appropriate, restarting follows similar logic to surgical recovery. Wait until you’re tolerating oral intake normally, GI function has returned to baseline, and any post-procedural nausea has resolved. Adding a GLP-1 medication back when you’re already nauseated from anesthesia or pain medication compounds discomfort unnecessarily.<\/p>\n For routine dental work with no sedation involved, there’s no reason to pause treatment and no restart protocol needed. Continue your medication on its normal schedule.<\/p>\n Routine dental care under local anesthesia: continue your GLP-1 medication normally and disclose it to your dentist as part of your standard medication list.<\/p>\n Sedated dental procedures or oral surgery: coordinate between your prescribing provider and dental team about an appropriate pre-procedure hold, following the same general framework as surgical pre-operative planning.<\/p>\n Ongoing oral health: be aware that reflux and reduced hydration on GLP-1 medications can affect dental health over time, and keep your dentist informed about any GI side effects you’re experiencing.<\/p>\nOral Surgery: A Closer Look<\/h2>\n
How GLP-1 Medications Affect Oral Health More Broadly<\/h2>\n
What to Tell Your Dentist<\/h2>\n
Restarting After a Dental Procedure<\/h2>\n
The Practical Summary<\/h2>\n